Question: As of August 2016, what was the market capitalisation of the company that developed the drug Losmapimod?
Sentence (from "Losmapimod"): Losmapimod (GW856553X) is a drug developed by GlaxoSmithKline which acts as a selective inhibitor of the enzyme family known as p38 mitogen-activated protein kinases.
Relevant evidence: Yes